| 2023 | Machine learning-based prediction of risk factors for abnormal glycemic control in diabetic cancer patients receiving nutrition support: a case–control study | 곽혜선; 이정 | Article |
| 2015 | Nanoparticle-based combination therapy for cancer treatment | 이혁진 | Article |
| 2018 | Priorities of a "good death" according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey | 이순남 | Article |
| 2016 | Rapid emergence and mechanisms of resistance by U87 glioblastoma cells to doxorubicin in an in vitro tumor microfluidic ecology | 이상혁; 김재상; 정연주 | Conference Paper |
| 2015 | Regulation of cancer cell death by a novel compound, C604, in a c-Myc-overexpressing cellular environment | 임재향 | Article |
| 2019 | Silver nanoparticles promote procoagulant activity of red blood cells: a potential risk of thrombosis in susceptible population | 임경민 | Article |
| 2012 | SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis | 김현석 | Review |
| 2018 | Submicromolar bisphenol A induces proliferation and DNA damage in human hepatocyte cell lines in vitro and in juvenile rats in vivo | 이윤실; 임경민; 김민정 | Article |
| 2016 | Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage | 이화정; 정우진; 창동신 | Article |
| 2015 | Synthesis and biological evaluation of 5-(fluoro-substituted-6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-alpha]pyridin-6-yl)imidazoles as inhibitors of transforming growth factor-beta type I receptor kinase | 신윤용; 김대기 | Article |
| 2021 | The cancer risk according to three subtypes of ANCA-associated vasculitis: A propensity score-matched analysis of a nationwide study | 문창모; 안성복 | Article |
| 2019 | The development of light-responsive, organic dye based, supramolecular nanosystems for enhanced anticancer therapy | 윤주영 | Review |
| 2022 | The role of factor xa-independent pathway and anticoagulant therapies in cancer-related stroke | 김형준 | Article |
| 2020 | Ubiquitin-proteasome system (UPS) as a target for anticancer treatment | 송은주 | Review |
| 2023 | Ubiquitin–proteasome system as a target for anticancer treatment—an update | 송은주 | Review |
| 2020 | Who should be given priority for public funding? | 배그린 | Article |
